Publications by authors named "Geoffrey Vannieuwenhuyse"
Article Synopsis
- Totally IntraVenous Acess Devices (TIVAD) are used for long-term access to the bloodstream in cancer patients, with two types being valved (TIVAD-V) and open-ended (TIVAD-O).
- A study involving 636 patients found that 8.7% of TIVADs were removed due to complications, mainly infections and occlusions, over a 54-month period.
- The results indicated no significant differences in complication rates or time-to-removal between TIVAD-V and TIVAD-O, with average removal times of 17.0 and 18.4 months respectively.
Introduction: Robot-assisted surgery is spreading worldwide, accounting for more than 1.2 million procedures in 2019. Data are sparse in the literature regarding the surgeon's mechanisms that mediate risk-taking during a procedure, especially robot-assisted.
View Article and Find Full Text PDF